Cargando...
Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore
BACKGROUND: CDK4/6 inhibitors have shown promising results for treating advanced breast cancer (ABC) and are routinely used in Singapore. In view of their high costs, it is important to assess their relative value compared to existing standards of care in the local setting. AIMS: This study evaluate...
Guardado en:
| Publicado en: | Cancer Rep (Hoboken) |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941436/ https://ncbi.nlm.nih.gov/pubmed/33085843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1308 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|